PILL Stock Overview
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Canntab Therapeutics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0 |
| 52 Week High | CA$0.02 |
| 52 Week Low | CA$0.005 |
| Beta | 1.43 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Recent updates
Shareholder Returns
| PILL | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | n/a | -3.9% | 1.2% |
| 1Y | n/a | 53.0% | 6.1% |
Return vs Industry: Insufficient data to determine how PILL performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how PILL performed against the Canadian Market.
Price Volatility
| PILL volatility | |
|---|---|
| PILL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: PILL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PILL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Richard Goldstein | canntab.ca |
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Canntab Therapeutics Limited Fundamentals Summary
| PILL fundamental statistics | |
|---|---|
| Market cap | CA$194.55k |
| Earnings (TTM) | -CA$3.36m |
| Revenue (TTM) | CA$73.48k |
0.0x
P/S Ratio0.0x
P/E RatioIs PILL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PILL income statement (TTM) | |
|---|---|
| Revenue | CA$73.48k |
| Cost of Revenue | CA$1.40m |
| Gross Profit | -CA$1.33m |
| Other Expenses | CA$2.03m |
| Earnings | -CA$3.36m |
Last Reported Earnings
Feb 28, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.086 |
| Gross Margin | -1,806.30% |
| Net Profit Margin | -4,566.80% |
| Debt/Equity Ratio | -87.8% |
How did PILL perform over the long term?
See historical performance and comparison